This has been a super positive journey
What Clinical Trials Show In clinical trials of FDA-approved semaglutide (Wegovy) and tirzepatide (Zepbound): Semaglutide (Wegovy): In large clinical trials of FDA-approved products, average weight loss was meaningful over roughly 68 weeks when paired with lifestyle support (reduced-calorie diet and increased physical activity)
If appropriate, theyll guide you through the next steps by completing a review of your health history and submitting any required documentation
The main concern is stacked GI side effects - both compounds slow digestion through different pathways, so combining them can amplify nausea, vomiting, and constipation
These are legitimate clinical questions - and they should be directed to the prescribing clinician, not answered by marketing materials or content articles
Endurance-based exercise, such as long-distance running or cycling, can also contribute to the loss of muscle mass if not accompanied by adequate protein consumption and resistance training
